United States · FDA National Drug Code directory
Lamivudine and Zidovudine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-1916_ae1913db-ec19-4f19-9ca8-0c524410de4c
- Product NDC
- 71335-1916
- Form
- TABLET
- Composition / generic term
- Lamivudine and Zidovudine
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180830
- Source listing expiry
- 20261231
Source-listed ingredients
- LAMIVUDINE — 150 mg/1
- ZIDOVUDINE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET in 1 BOTTLE (71335-1916-1) · 71335-1916-1
- 60 TABLET in 1 BOTTLE (71335-1916-2) · 71335-1916-2
- 4 TABLET in 1 BOTTLE (71335-1916-3) · 71335-1916-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →